SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-060509
Filing Date
2019-11-06
Accepted
2019-11-06 16:13:28
Documents
3
Period of Report
2019-11-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-22106_18k.htm 8-K 26287
2 EX-99.1 a19-22106_1ex99d1.htm EX-99.1 105664
3 GRAPHIC g221061mmi001.jpg GRAPHIC 3619
  Complete submission text file 0001104659-19-060509.txt   138331
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31918 | Film No.: 191196441
SIC: 2836 Biological Products, (No Diagnostic Substances)